04.01.2024 | CORRESPONDENCE
Re: Statistical inference and effect measures in abstracts of randomized trials, 1975-2021
Erschienen in: European Journal of Epidemiology
Einloggen, um Zugang zu erhaltenExcerpt
Stang and Rothman recently presented an informative systematic review of statistical inference and effect measures in abstracts of randomized controlled trials between 1975 and 2021 [1]. In the review, they write:…In 2016, the American Statistical Association [ASA] explicitly stated, “The widespread use of ‘statistical significance’ (generally interpreted as ‘p ≤ 0.05’) as a license for making a claim of a scientific finding (or implied truth) leads to considerable distortion of the scientific process.” [2]. More recently, the ASA provided an even stronger statement that “it is time to stop using the term ‘statistically significant’ entirely. Nor should variants such as ‘significantly different,’ ‘p < 0.05,’ and ‘nonsignificant’ survive, whether expressed in words, by asterisks in a table, or in some other way. Whether it was ever useful, a declaration of ‘statistical significance’ has today become meaningless” [3].